ATI RN Pharmacology 2019 I

Extract:

Question 1 of 5

A nurse recently administered filgrastim intravenously to a client who has cancer and is receiving cytotoxic chemotherapy. For which of the following data, discovered after the medication was administered, should the nurse file an incident report?

A. The client had chemotherapy 12 hr before the medication was administered. B. The medication vial sat at room temperature for 2 hr before it was administered. C. The client's absolute neutrophil count was 2,500/mmÂ³ before the medication was administered. D. The nurse flushed the client's IV line with dextrose 5% in water before and after the medication was administered.

Correct Answer: A

Rationale: The correct answer is A because administering filgrastim intravenously within 24 hours of cytotoxic chemotherapy can increase the risk of bone pain and other adverse effects. This information is crucial for monitoring and managing potential complications.
Choice B is incorrect because filgrastim can be stored at room temperature for a short period without affecting its effectiveness.
Choice C is incorrect because an absolute neutrophil count of 2,500/mm³ is within the normal range for administering filgrastim.
Choice D is incorrect because flushing the IV line with dextrose 5% in water is a standard procedure and not a reason for filing an incident report.

Question 2 of 5

Correct Answer:

Rationale:

Question 3 of 5

Correct Answer:

Rationale:

Question 4 of 5

Correct Answer:

Rationale:

Question 5 of 5

Correct Answer:

Rationale:

ATI RN Pharmacology 2019 I | Nurselytic

Nurselytic

ATI RN

ATI RN